Covid-Weary Americans Spark Billions in Corporate Writedowns

  • Pfizer cuts sales outlook as drugmakers see waning shot demand
  • A wider reckoning is threatening test makers, mask producers

Vaccine makers and pharmacy chains are seeing a decline in people getting Covid shots.

Photographer: Hannah Beier/Bloomberg
Lock
This article is for subscribers only.

Covid-19 reshaped the health-care industry. The waning of the pandemic is reshaping it all over again.

Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid shots. Makers of at-home rapid tests are going belly-up. Companies that made personal protective equipment have shut down.